



A study of the management of group B 
streptococcal colonisation in pregnant women: 
Benefits and risks of preventative modalities 
 
A thesis presented in fulfilment of the requirements for the degree of 
Doctor of Philosophy, Midwifery 
Kathryn Tina Braye 
Centre for Midwifery, Child and Family Health 
Faculty of Health 




Certificate of original authorship 
I, Kathryn Tina Braye, declare that this thesis is submitted in fulfilment of the 
requirements for the award of Doctor of Philosophy, Midwifery, in the Faculty of Health 
at the University of Technology Sydney. 
This thesis is wholly my own work unless otherwise referenced or acknowledged. In 
addition, I certify that all information sources and literature used are indicated in the 
thesis. This document has not been submitted for qualifications at any other academic 
institution. This research is supported by the Australian Government Research Training 
Program. 
Signature: 
Date: 20th March 2020
Production Note:




It is unbelievable to me that I am sitting here, very close to my 60th birthday and just after 
my 36th wedding anniversary writing a dedication in a PhD thesis. My PhD thesis no less. 
I left school at 16, barely understanding the significance of a university (although 
knowing I wanted to continue my education). Well I’ve done that! 
I am dedicating this PhD thesis to myself, as well as my parents. It has been a long haul 
and I have finally made it. I feel very proud. I would like to honour all mothers and babies 
whose birth journeys have been part of this work. I would like to honour my parents too, 
Joyce and Raymond Perry. My mother, Joyce died way too young, the same age as I am 
now. My babies were small, and she never knew I would still be studying when they were 
all grown. My dad, Raymond, died just before I started PhD studies, in the days before 
he died, I told him I was going to be a doctor and complete a PhD. I’m not sure he 
completely understood but actually it wouldn’t matter if I had told him I was going to 
support a woman to birth her baby, walk 720km to Santiago de Compostela, or fly to the 
moon and back, he was always so proud of his little girl. 
I could not have even enrolled without the help of Stephen. He has supported every one 
of my academic and professional endeavours. I am very grateful to him. My family, 
children Nicholas, Anna and Owen, and my friends (who are also my family), both those 
in the Northern hemisphere and those in Australasia. It can’t be easy to continue to support 
someone who lives and breathes her PhD topic. Particular thanks and hugs go to Kat 
Flower and Elise Putt for the hours they have given me and for the encouragement and 
non-wavering confidence that I could finish. Advisors, co-authors and teachers and 
helpers, Fenglian Xu, Koert De Waal, Elise Putt, Kat Flower, Jean Ball, Mark Jones, UTS 
and HNE library staff, graduate research school staff, fellow colleagues, friends and 
students at University of Technology Sydney (UTS) and Hunter New England Health 
(HNEH). 
Last but not least, my supervisors, especially Professor Maralyn Foureur, A/ Professor 
John Ferguson and Dr Christine Catling. Thank you for your expertise and guidance and 
for standing by me and propping me up when I have needed it. Also thank you to Professor 
iv 
 
Deb Davis and Dr Amy Monk for their supervision and wise counsel early in my 
candidature, and Dr Fenglian Xu who patiently sat by my side through longs hours of 
wading through data and syntax in SPSS. 
One of my core values (thank you Carolyn and Ilze) is making a positive difference. 
Mothers want the best for their babies, no matter what their age. A long-standing vision 
throughout the period of my candidature was that the work in this thesis would add to the 
body of knowledge around the complex issue of Group B streptococcus (GBS) risk in 
pregnancy and enable and empower women to make (sometimes difficult) decisions and 











To my parents, Joyce and Raymond Perry 
vi 
 
Scholarships and awards during candidature 
The following scholarships and awards are acknowledged with thanks: 
 2016: UTS Research Student Development award ($3000) 
 2017: Pat Brodie ACM scholarship for the Australian consortium for social 
and political research (APSCRI): Fundamentals of statistics 5 day course 
($3000) 
 2017: Edith Cavell Trust scholarship award 2018: ($4000) 
 2018: Annual Caroline Homer Writing Prize for the best new author 
published in Women and Birth (WOMBI), the Journal of the Australian 
College of Midwives. Winner ($1000) 
 2019: Moyra Lewis ALSO instructor of the year award –Finalist. 




Presentations at conferences/meetings/reviews/activities 
associated with this thesis 
 2015: Braye, K., Catling, C., Ferguson, J., Foureur, M. Group B 
streptococcus: Are we doing more harm than good? 19th Biennial ACM 
Conference, Gold Coast, Queensland. Poster presentation 
 2015: Braye, K., Catling, C., Ferguson, J., Foureur, M. To douche or not to 
douche? Chlorhexidine for group B streptococcus (GBS) in otherwise well, 
healthy pregnant women. Research Student Forum. University Technology 
Sydney. Oral presentation 
 2015: Braye, K., Group B streptococcus: Are we doing more harm than 
good? Multi- disciplinary meeting. Department of Maternity & Gynaecology 
John Hunter Hospital, Newcastle, New South Wales. Oral presentation 
 2015: Braye, K. Group B streptococcus: Are we doing more harm than 
good? Research Students Forum. University of Technology Sydney. Oral 
presentation 
 2015: Braye, K. Are current guidelines for group B streptococcus causing 
iatrogenic microbial and epigenetic harm for short term gain? Australian 
College of Midwives, NSW Branch annual conference, Leura, New South 
Wales. Oral presentation 
 2015: Braye, K. Group B streptococcus: Are we doing more harm than 
good? Belmont Midwifery Group Practice midwives. Belmont. New South 
Wales Oral presentation. Invited speaker 
 2016: Braye, K. Group B streptococcus: Are we doing more harm than 
good? Hunter New England infectious diseases physicians and 
microbiologists. Newcastle. New South Wales Oral presentation. Invited 
speaker 
 2016: Braye, K. Insights of a 3rd year PhD candidate. Research Students 
Forum. University of Technology Sydney. Oral presentation 
viii 
 
 2016: Braye, K. Group B streptococcus, are we doing more harm than good? 
Informing the narrative on intrapartum prophylaxis. Australian College of 
Midwives. Webinar production. Initial research findings. Invited speaker 
 2016: Braye, K., Are current guidelines for Group B streptococcus causing 
iatrogenic microbial and epigenetic harm for short term gain? 11th 
International normal labour and birth conference, Sydney. Oral presentation 
 2016: Braye, K. Stage one assessment and presentation in fulfilment of the 
requirements for the degree of Doctor of Philosophy, Midwifery. University 
of Technology Sydney. Written and oral presentation 
 2017: Braye, K. Why increase the dose of intrapartum antibiotic prophylaxis 
for maternal GBS colonisation: Are we doing more harm than good? Virtual 
international day of the midwife conference, Sydney. On-line presentation 
 2017: Braye, K. Group B streptococcus, are we doing more harm than good? 
Informing the narrative on intrapartum prophylaxis. Initial research findings. 
31st ICM triennial congress, Toronto, Canada. Oral presentation 
 2017: Braye, K. Group B streptococcus, are we doing more harm than good? 
Informing the narrative on intrapartum prophylaxis. Initial research findings. 
Meeting of Hunter New England Neonatology clinicians. Newcastle, New 
South Wales. Oral presentation. Invited speaker 
 2017: Braye, K. Group B streptococcus, are we doing more harm than good? 
Informing the narrative on intrapartum prophylaxis. Initial research findings. 
Education meeting for the John Hunter Hospital clinical midwifery 
educators. Newcastle, New South Wales. Oral presentation. Invited speaker 
 2017: Braye, K. Group B streptococcus, are we doing more harm than good? 
Informing the narrative on intrapartum prophylaxis. Initial research findings 
Hunter valley midwives association. Newcastle, New South Wales. Oral 
presentation. Invited speaker 
 2017: Braye, K. Group B streptococcus, are we doing more harm than good? 
Informing the narrative on intrapartum prophylaxis. Initial research findings. 
The third Australian nurses and midwives conference. Newcastle, New South 
Wales. Oral presentation 
ix 
 
 2017: Braye, K. The truth is out there! Informing the narrative on 
intrapartum prophylaxis for GBS management. The 20th Australian college 
of midwives national conference. Adelaide, South Australia. Oral 
presentation 
 2017: Braye, K. What are the maternal Group B streptococcal 
colonisation rates and GBS management experience of a cohort 
of pregnant women and their babies 2006- 2013? Research 
Students Forum, University of Technology Sydney. Oral 
presentation 
 2018: Braye, K. Review of Microbirth online GBS course. Invited reviewer 
 2018: Braye, K. Optimising maternal wellbeing. Australian College of 
Midwives Victoria Branch. Annual update. Oral presentation. Invited speaker 
 2018: Braye, K. Group B streptococcus (GBS) prophylaxis: Does it cause 
iatrogenic microbial harm for minimal short term gain? Update for 
clinicians. Alice Springs. On-line presentation. Invited speaker 
 2018: Braye, K. The Group B Strep dilemma: Are we doing more harm than 
good? 3 minute thesis (3MT) finalist. Research Students Conference. 
University of Technology Sydney 
 2018: Braye, K. Case study discussion New Zealand College of Midwives. 
Rotorua, New Zealand 
 2018: Braye, K. Stage two assessment and presentation in fulfilment of the 
requirements for the degree of Doctor of Philosophy, Midwifery. University 
of Technology Sydney. Written presentation and discussion 
 2018: Braye, K. Epidemiology of early-onset sepsis in a local health district 
2006- 2016. Annual update for Sydney Midwifery Educators. University of 
Technology Sydney 
 2018: Braye, K. Epidemiology of early-onset sepsis in a local health district 




 2019: Braye, K. Group B streptococcal screening, intrapartum antibiotic 
prophylaxis and neonatal early-onset infection rates in the Hunter New 
England local health district: 2006-2016. The fourth Australian nurses and 
midwives conference, Newcastle, New South Wales. Oral presentation 
 2019: Braye, K. Presented by Scarf, V. Antibiotic prophylaxis for women 
who are screened positive for GBS colonisation: compliance with guidelines. 
The International Normal Labour and Birth Conference, Grange over Sands, 
Cumbria, UK. Oral presentation
xi 
 
Publications in peer reviewed journals during candidature 
This thesis contains four manuscripts outlined below, three published and one under peer 
review. The manuscripts have individual statements of authors’ contributions to each 
manuscript. The CRediT Taxonomy as used by the journal, PLoS ONE, has been 
modified and used as a template to describe each author’s individual contributions (PLoS 
ONE). 
Area of contribution Role Definition 
Conceptualisation Ideas; formulation or evolution of overarching research goals 
and aims 
Data curation Management activities to annotate (produce metadata), scrub 
data and maintain research data (including software code, 
where it is necessary for interpreting the data itself) for initial 
use and later reuse 
Formal analysis Application of statistical, mathematical, computational, or 
other formal techniques to analyse or synthesize study data 
Funding acquisition Acquisition of the financial support for the project leading to 
this publication 
Investigation Conducting a research and investigation process, specifically 
performing the experiments, or data/evidence collection 
Methodology Development or design of methodology; creation of models 
Supervision Oversight and leadership responsibility for the research 
activity planning and execution, including mentorship 
external to the core team 
Validation Verification, whether as a part of the activity or separate, of 
the overall replication/reproducibility of results/experiments 
and other research outputs 
xii 
 
Visualisation Preparation, creation and/or presentation of the published 
work, specifically visualisation/data presentation 
Writing – Original Draft 
Preparation 
Creation and/or presentation of the published work, 
specifically writing the initial draft (including substantive 
translation) 
Writing – Review & 
Editing 
Preparation, creation and/or presentation of the published 
work by those from the original research group, specifically 





Author’s contributions to published manuscripts 
Publication 1 
Braye, K., Ferguson, J., Davis, D., Catling, C., Monk, A., Foureur, M. 2019. 
‘Effectiveness of intrapartum antibiotic prophylaxis for early-onset group B 
streptococcal infection: An integrative review’. Women and Birth vol.31 no.4 pp. 
244-253 
Area of contribution Estimated percentage of contribution 
Conceptualisation KB 60%, MF 25%, CC 10%, DD 5% 
Data Curation KB 80%, EP 20% 
Formal Analysis KB 60% MF 40% 
Methodology KB 70%, MF 20%, AM 10% 
Supervision MF 70%, CC 20%, DD 10%, JF 10%, AM 10% 
Validation KB 50%, MF 40%, AM 5%, JF 5% 
Visualisation KB 50%, MF 30%, CC 10%, DD 5%, JF 5% 
Writing – Original Draft Preparation KB 100% 
Writing – Review & Editing KB 50%, MF 30%, CC 10%, JF 10% 
Publication 2 
Braye, K., Foureur, M., de Waal, K., Jones, M., Putt, E., Ferguson, J. 2019. 
‘Epidemiology of neonatal early-onset sepsis in a geographically diverse Australian 
health district 2006-2016’. PLoS ONE vol.14 no.4 
xiv 
 
Area of contribution Estimated percentage of contribution 
Conceptualisation KB 60%, JF 40% 
Data Curation KB 50%, EP 30%, MJ 10%, JF 10% 
Formal Analysis KB 60%, MJ 40% 
Methodology KB 40%, JF 30%, MF 15%, MJ 5%, 
Supervision JF 50%, MF 40%, KD 10%, 
Validation KB 30%, MF 30%, KD 5%, EP 5%, JF 30% 
Visualisation KB 60%, EP 20%, MF 20% 
Writing – Original Draft Preparation KB 100% 
Writing – Review & Editing KB, 40%, JF 30%, MF 20%, KD 5%, MJ 5%, 
Publication 3 
Braye, K., Foureur, M., de Waal, K., Jones, M., Putt, E., Ferguson, J. 2019, ‘Group 
B streptococcal screening, intrapartum antibiotic prophylaxis, and neonatal early- 
onset infection rates in an Australian local health district. PLoS ONE vol.14 no.4 
Area of contribution Estimated percentage of contribution 
Conceptualisation KB 70%, MF 30% 
Data Curation KB 50%, MJ 10%, EP 30%, JF 10% 
Formal Analysis KB 60%, MJ 40% 
Methodology KB 50%, MF 30%, MJ 10%, JF10% 
Supervision JF 50%, KW, 10%, MF 40% 
Validation KB 50%, MF,10%, KD 5%, MJ 10%, EP 5%, JF 20% 
Visualisation KB 70%, MJ 30%, MF 10% 
Writing – Original Draft Preparation KB 100% 
Writing – Review & Editing KB 40%, JF 30% MF 10%, KW 5%, MJ 10% EP 5%, 
Publication 4 
Braye, K., Ball, J., Foureur, M. 2019. Antibiotic prophylaxis for women who are 
screened positive for GBS colonisation: Clinical compliance with guidelines. Under 
review with the journal Midwifery. 
xv 
 
Area of contribution Estimated percentage of contribution 
Conceptualisation KB 100% 
Data Curation KB 100% 
Formal Analysis KB 60%, JB 40% 
Methodology KB 50%, MF 20%, JB 30% 
Supervision MF 100% 
Validation MF 70%, JB 30% 
Visualisation KB 50%, MF 30%, JB 20% 
Writing – Original Draft Preparation KB 100% 
Writing – Review & Editing KB 50%, MF 30%, JB 20% 
xvi 
 
Table of contents 
Certificate of original authorship ................................................................... ii 
Acknowledgements ....................................................................................... iii 
Dedication ...................................................................................................... v 
Scholarships and awards during candidature ................................................ vi 
Presentations at conferences/meetings/reviews/activities associated with this 
thesis............................................................................................................. vii 
Publications in peer reviewed journals during candidature .......................... xi 
Author’s contributions to published manuscripts ....................................... xiii 
Publication 1 .......................................................................................... xiii 
Publication 2 .......................................................................................... xiii 
Publication 3 ......................................................................................... xiv 
Publication 4 .......................................................................................... xiv 
Table of contents ......................................................................................... xvi 
Abbreviations .............................................................................................. xix 
Definitions ................................................................................................... xxi 
List of tables ............................................................................................... xxv 
List of figures ............................................................................................ xxvi 
Thesis Abstract ......................................................................................... xxvii 
Chapter 1 ........................................................................................................ 1 
Background .................................................................................................... 1 
Introduction ............................................................................................... 1 
Section 1 .................................................................................................... 3 
Section 2 .................................................................................................. 16 
Summary of Chapter 1 ............................................................................ 28 
Chapter 2 ...................................................................................................... 29 
Effectiveness of intrapartum antibiotic prophylaxis for early-onset group B 
streptococcal infection: An integrative review ............................................ 29 
Chapter preface ....................................................................................... 29 
Abstract ................................................................................................... 29 
Summary of relevance............................................................................. 31 
Introduction ............................................................................................. 32 
Background ............................................................................................. 32 
Method .................................................................................................... 37 
Findings ................................................................................................... 44 
Discussion ............................................................................................... 49 
Conclusion .............................................................................................. 53 
xvii 
 
References ............................................................................................... 55 
Chapter 3 ...................................................................................................... 59 
Epidemiology of neonatal early-onset sepsis in a geographically diverse 
Australian health district 2006-2016 ............................................................ 59 
Chapter preface ....................................................................................... 59 
Abstract ................................................................................................... 59 
Introduction and Background .................................................................. 60 
Aim .......................................................................................................... 62 
Materials and Methods ............................................................................ 62 
Results ..................................................................................................... 66 
Discussion ............................................................................................... 73 
References ............................................................................................... 77 
Chapter 4 ...................................................................................................... 80 
Group B streptococcal screening, intrapartum antibiotic prophylaxis, and 
neonatal early-onset infection rates in an Australian local health district: 
2006-2016 .................................................................................................... 80 
Chapter preface ....................................................................................... 80 
Abstract ................................................................................................... 80 
Introduction ............................................................................................. 81 
Background ............................................................................................. 82 
Aims ........................................................................................................ 84 
Methods ................................................................................................... 85 
Results ..................................................................................................... 88 
Discussion ............................................................................................... 94 
References ............................................................................................... 99 
Chapter 5 .................................................................................................... 104 
Antibiotic prophylaxis for women who screen positive for group B 
streptococcal colonisation: Clinician compliance with guidelines ............ 104 
Chapter preface ..................................................................................... 104 
Abstract ................................................................................................. 104 
Introduction/background ....................................................................... 106 
Methods ................................................................................................. 109 
Results ................................................................................................... 111 
Discussion and conclusion .................................................................... 117 
References ............................................................................................. 122 
Chapter 6 .................................................................................................... 128 
Discussion .................................................................................................. 128 
Significance and contribution to the wider body of knowledge ........... 133 
Are there other reasons for low rates of EOGBS? ................................ 134 
Recommendations for future research and clinical practice arising from 
this work ................................................................................................ 135 
Conclusion ............................................................................................ 137 
Appendices ................................................................................................. 139 
Appendix 1 – Publication 1 ................................................................... 139 
Appendix 2 – Publication 2 ................................................................... 149 
xviii 
 
Appendix 3 – Publication 3 ................................................................... 163 
Appendix 4 – Ethics approval from HNEHREC .................................. 178 
Appendix 5 – Ethics Approval from UTS HREC ................................. 179 







3MT Three minute thesis 
ACM Australian College of Midwives 
ACOG American College of Obstetricians and Gynaecologists 
EOGBS Early-onset group B streptococcal infection 
EOS Early-onset sepsis 
g Grams 
GBS Group B streptococcus 
HMO Human milk oligosaccharides 
HNE Hunter New England 
HNELHD Hunter New England Local Health District 
HREC Human Research Ethics Committee 
IAP Intrapartum Antibiotic Prophylaxis 
IV Intravenous 
JHH John Hunter Hospital 
LHD Local Health District 
LMC Lead Maternity Carer 
LOGBS Late-onset group B streptococcus 
NICE National Institute of Health Care and Excellence 
NZCOM New Zealand College of Midwives 
PCR Polymerase chain reaction 




RCOG Royal College of Obstetricians and Gynaecologists 
ROM Release or rupture of membranes (the term release is preferred by 
the author of this work as it aligns with my preference for woman 
friendly terminology) 
RSF Research student forum 
SROM Spontaneous release or rupture of membranes 
UK United Kingdom 
USA United States of America 




Adequate IAP Common definition: ≥4 hours of IAP before birth of the baby 
Bacteria Microscopic living organisms, usually one-celled, that can be 
found everywhere. They can be beneficial or pathogenic 
Blood culture A blood test to detect and identify bacteria in the blood 
Cerebrospinal 
fluid 
A normally sterile body fluid found within and surrounding the 
brain and spinal cord 
Colonisation The presence of bacteria on a body surface, mucous membrane or 
body niche without causing disease in the person 
Commensal Living in a relationship in which one organism derives food or 
other benefits from another organism without hurting or helping it 
Dysbiosis An imbalance between the types of organism present in the 
microbiome 
Early-onset Within 72 hours of birth 
Early-onset GBS 
sepsis 
Sepsis arising within 72 hours caused by the GBS bacteria as 
shown by a positive blood or cerebrospinal fluid culture 
Early-onset sepsis Sepsis arising within 72 hours of birth. Generally microbiological 
culture-confirmed events are included 
Eligible 
pregnancy 
A woman’s pregnancy that reaches ≥35 weeks gestation and 
therefore eligible for universal GBS screening. The term 
pregnancy rather than woman was used as many women had 
more than one pregnancy over the study period 
Eligible preterm A baby ≥35 weeks, but <37 weeks gestation, whose mother is 
therefore eligible for universal GBS screening 
Eligible term 
baby 
A baby ≥37 weeks, whose mother is therefore eligible for 
universal GBS screening 
xxii 
GBS management The medical intervention for the prevention or reduction of the 
likelihood of having a baby with EOGBS. The management 
involves selecting women who are deemed most at risk and 
then offering IAP. After birth women may be asked to remain 




Group B streptococcus GBS also known as Streptococcus 
agalactiae is a commensal bacterium forming part of the 
human microbiota or microbiome colonising the 
gastrointestinal and genitourinary tract 
High-income 
country 
The World Bank defines a high-income country as one that has a 








IAP for at least 4 hours, repeated 4-hourly until birth 




Immunoglobulin G (IgG) is a type of antibody. It is the 
most common antibody found in blood circulation 




Aims to reduce the likelihood of vertical transmission of maternal 





GBS bacteria form part of the human microbiota or 
microbiome colonising the gastrointestinal and genitourinary 
tract of up to 30% of healthy human adults (asymptomatic 
carriers), including pregnant women 
Microbiome The genetic make-up of the whole of the microbiota: i.e. the genes 
from bacteria, eukaryotes, archaea and viruses 
Microbiota Microorganisms that are found within a specific environment 
Neonatal A newborn infant, or neonate under 28 days of age 
Neonatal GBS 
colonisation 
GBS bacteria may be passed from mother to her baby in utero 
prior to or during birth as part of a baby’s founding 
microbiome, this leads to neonatal GBS colonisation which is 
usually asymptomatic and harmless 
Pathogenic 
bacteria 
Bacteria that cause disease 
Prophylaxis Measures designed to preserve health and prevent disease 
Screening The systematic application of a test or inquiry to identify 
individuals at sufficient risk of a specific disorder to benefit from 




Selection of women whose babies may benefit from IAP; 
screening can be universal or based on certain risk factors 
Sepsis A potentially life-threatening condition caused by the body's 
response to an infection. The body normally releases chemicals 
into the bloodstream to fight an infection. Sepsis occurs when 
the body's response to these chemicals is out of balance, 
triggering changes that can damage multiple organ systems 
Symbiosis Interaction between two different organisms living in close 
physical association, typically to the advantage of both 
xxiv 
Therapeutic Treats, prevents or alleviates symptoms of disease 
Treatment Medical care given to a patient for an illness or injury 
 
xxv 
List of tables 
Table 2.1 - Examples of search strategy (Medline Database) ......................................... 38 
Table 2.2 - Systematic review and meta-analysis plus randomised controlled trials of the 
effectiveness of intrapartum antibiotic prophylaxis (IAP) on early-onset group B 
streptococcal infection .................................................................................................... 42 
Table 2.3 - Observational studies of the effectiveness of intrapartum antibiotic 
prophylaxis on early-onset group B streptococcal infection ........................................... 43 
Table 3.1(a) & (b) -  Sample characteristics of women, their pregnancies and babies ... 67 
Table 3.2 - Term and preterm early-onset sepsis by organism ....................................... 72 
Table 4.1 - Pregnancies resulting in live born babies per unit 2006-2016 ...................... 85 
Table 4.2 - Eligible pregnancies, maternal GBS screening and colonisation rates, and 
IAP provision .................................................................................................................. 91 
Table 5.1 - Sample characteristics of ^eligible screened women, positive for GBS, and 
their babies .................................................................................................................... 111 
Table 5.2 - Descriptive analysis of IAP provision and timing of IAP relative to birth 112 
Table 5.3 - Variables in relation to provision of IAP in accord with local guidelines.. 115 
 
xxvi 
List of figures 
Figure 1.1 - The interrelation of the literature review and three resulting studies .......... 27 
Figure 2.1 - Inclusion flowchart ...................................................................................... 40 
Figure 3.1 - Inclusions and exclusions ............................................................................ 63 
Figure 3.2 - Early-onset sepsis events per 1000 live births............................................. 69 
Figure 3.3 - Early-onset sepsis events by gestation ........................................................ 70 
Figure 4.1 - Inclusions and exclusions ............................................................................ 89 
Figure 4.2 - Maternal GBS colonisation ......................................................................... 90 
Figure 4.3- Screened versus unscreened pregnancies and rates of EOGBS ................... 92 
Figure 4.4 - Incidence of term and preterm EOGBS 2006 - 2016 .................................. 93 
Figure 5.1 - Number of benzylpenicillin doses given in accord with guidelines .......... 113 
Figure 5.2 - Overview of stepwise clinician’s adherence to guidelines in the study 





In high-income countries ~ 30% of women and their babies are exposed to intrapartum 
antibiotic prophylaxis (IAP), for the prevention of neonatal early-onset group B 
streptococcal infection (EOGBS). This intervention aims to lower the risk of EOGBS but 
IAP is not without its own risks. Emerging evidence of the potential impact of antibiotics 
on the maternal/baby’s microbiome is concerning. Evidence of the effectiveness of IAP 
and its application was needed to establish if current management was the optimum 
strategy for the reduction of EOGBS. 
Purpose 
To establish the impact of the normally commensal bacteria, group B streptococcus 
(GBS), on rates of neonatal early-onset sepsis (EOS) in one large health district; to 
describe local management of maternal GBS colonisation; and assess clinicians’ 
adherence to GBS guidelines. 
Methods 
An integrative literature review was undertaken to examine the effectiveness and 
implications of IAP. Subsequently, two retrospective observational studies explored 
temporal trends in EOS, GBS management, and EOGBS, in one large health service over 
11 years, using logistic regression and covariates for potential modifiers. A third study 
analysed a subset of women using ordered logistic regression. A 5% margin of error and 
a 95% confidence interval was used throughout. 
Results 
This research found management of GBS risk was sub-optimal. Clinical trials reported 
high effectiveness, but they had major methodological flaws. Observational studies 
showed poor adherence to GBS management. Whilst scant consideration was given to 
short-term risks; long-term consequences were not addressed. 
In this work, group B streptococcus was the most common cause of EOS in term babies. 
xxviii 
All cause EOS reduced significantly over time; EOGBS reduced but this did not reach 
statistical significance. Analysis of blood culture utilisation revealed intensity of 
surveillance did not change. Eighteen babies were diagnosed with EOGBS (0.19/1000 
live births), ten of these were term. Seven were born to mothers screened negative for 
GBS. No evidence of difference in rates of EOGBS between screened and unscreened 
pregnancies was found. Prophylaxis in accord with local guidelines was received by one 
third of eligible women. Most missed opportunities for IAP were unavoidable, and mainly 
due to lack of time between admission for labour and birth. Despite this, rates of EOGBS 
were extremely low at 0.19/1000 live births. 
Conclusion 
Evidence for screening and IAP is poor. Current management has serious limitations, and 
risks may outweigh benefit. Overall, management of GBS risk warrants urgent 
reconsideration. Research is needed to understand factors, other than IAP, that may be 
contributing to protection from EOGBS. 
